History & Overview Annual Report President's Pages Center News Community Affairs

Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS

Press Releases In the News Information for Journalists News@MSKCC

Manhattan New Jersey Long Island Westchester

Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online

Prostate Cancer

Our Approach & Expertise

Our Team of Experts

From Our Prostate Cancer Experts

Clinical States Treatment Model

Prostate Cancer Treatment & Investigational Approaches

Our Clinical Trials

Survivorship & Support

Patient Stories

Prostate Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for prostate cancer, listed by clinical state.

Clicking a link below will scroll the
page down to the relevant section

No Cancer Diagnosis: Prevention and High-Risk Screening
Localized Disease
Rising PSA After Primary Therapy
Metastatic Disease After Testosterone-Reducing Therapy
Other Trials

No Cancer Diagnosis: Prevention and High-Risk Screening

We have no prostate cancer clinical trials for this clinical state at this time.

Localized Disease

A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Cox, Brett, MD

[Protocol 09-035]
A Phase II Study of Focal Cryoablation in Low-Risk Prostate Cancer
Eastham, James, MD

[Protocol 08-118]
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Eastham, James, MD

[Protocol 07-041]
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy
Yamada, Yoshiya, MD

[Protocol 06-122]
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
Yamada, Yoshiya, MD

[Protocol 07-120]
High Intensity Focused Ultrasound for the Treatment of Low-Risk, Localized Prostate Cancer
Eastham, James, MD

[Protocol 08-016]
Neoadjuvant Hormonal Therapy in Combination with Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 06-160]
Radiotherapy Plus Sildenafil (Viagra) to Preserve Erectile Function Versus Radiotherapy Alone in Localized Prostate Cancer
Zelefsky, Michael, MD

[Protocol 05-007]
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy
Eastham, James, MD

[Protocol 04-132]

Rising PSA After Primary Therapy

A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery
Morris, Michael, MD

[Protocol 07-101]
A Phase III Trial of Short-Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed-Only Radiotherapy in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
Zelefsky, Michael, MD

[Protocol 09-102]

Metastatic Disease After Testosterone-Reducing Therapy

A Phase I Study of Vaccine Replicon Particles (VRP) Expressing Prostate-Specific Membrane Antigen (PSMA) in Patients with Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 08-028]
A Phase I/II Study of HE3235 in Patients with Prostate Cancer
Morris, Michael, MD

[Protocol 08-090]
A Phase II Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer Following Disease Progression on Docetaxel-Based Chemotherapy
Rathkopf, Dana, MD, PhD

[Protocol 08-102]
A Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Morris, Michael, MD

[Protocol 09-008]
A Phase III Study of Abiraterone Acetate Plus Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
Rathkopf, Dana, MD, PhD

[Protocol 09-032]
A Phase III Study of Docetaxel with and without Dasatinib in Castration-Resistant Prostate Cancer
Morris, Michael, MD

[Protocol 09-050]
A Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Bone Problems in Men with Prostate Cancer that Has Spread to the Bone
Morris, Michael, MD

[Protocol 06-091]
A Phase Ib Study of Panobinostat (LBH589) with Docetaxel and Prednisone in Patients with Hormone-Refractory Prostate Cancer
Rathkopf, Dana, MD, PhD

[Protocol 07-163]
Phase I Study of Alpharadin^TM in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Morris, Michael, MD

[Protocol 08-058]

Other Trials

2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer
Morris, Michael, MD

[Protocol 00-095]
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
Mulhall, John, MD

[Protocol 09-005]
A Study of Avanafil for the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy
Mulhall, John, MD

[Protocol 09-064]
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer
Scardino, Peter, MD

[Protocol 02-042]
Radiotherapy Plus Sildenafil (Viagra) to Preserve Erectile Function Versus Radiotherapy Alone in Localized Prostate Cancer
Zelefsky, Michael, MD

[Protocol 05-007]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org